In this episode: emerging versus mature markets, mobile adoption, field sales force, localization, iphones in china, global mobile strategy, market regulation challenges, content management systems (CMS), translations

In this episode: physician relationships, rep-like services, sales rep replacement, sales talent, mobile transition, edetailing, salesforce shifts, brand benefits, sales rep experience, content, iPads, conversations, Gartner, Manhattan Research Associates, research, news, patient education, self-reported data

In this episode: physicians’ transition to hospitals, new product education, multichannel communication, sales reps, hcp interactions, patient education, content, data analysis, sales rep training, non-personal selling, rep-based selling

In this episode: category promotion, branded products, unbranded promotion, promotional risk, pharm promotion, good promotional practices, product website links, scientific speech

IIn this episode: Reprint Pros & Cons, reprints validity, regulatory history, public health issues, patient risk, reprint delivery, unsolicited requests, sales reps, medical affairs, bibliography, cover letter, peer-to-peer, documentation, disclaimers, system compliance, training

In this episode: medical reprints, first amendment, limited protections, commercial speech, drug promotion, device promotion, government, advisory opinion, litigation, FDA

In this episode: Good Reprint Practices, Good Promotional Practices, GPP, off label promotion, medical reprints, promotional policies, reprint distribution, reprint promotional reviews, clinical evidence, regulatory requirements, FDA, review committees

In this episode: promotional deception, warning disclosures, author financial ties, funding disclosures, information evaluation, Sunshine Laws, clinical trials, market research, CME, off label promotion, drug labeling, disease, indication, dosing, device, diagnostic tests, intended use

In this episode: enforcement themes, warning letters, FDA compliance, off label promotion, approved labeling, unsubstantiated claims, Lanham Act, risk information, net impressions, sales messages, review committees, evidence quality

In this episode: medical affairs, medical information, unsolicited requests, clinical reprints, FDA guidance, patient care, off-label usage, documentation, departmental structure and reporting, credibility, training, knowledge management, sales collaboration